Total Payments
$970.90
2022 Payments
$37.31
Companies
19
Transactions
65
Medicare Patients
3,403
Medicare Billing
$277,286
Payment Breakdown by Category
Food & Beverage$970.90 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $970.90 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $239.60 | 16 | $0 (2021) |
| Novo Nordisk Inc | $123.04 | 9 | $0 (2021) |
| ABBVIE INC. | $80.90 | 5 | $0 (2022) |
| Allergan, Inc. | $70.39 | 4 | $0 (2020) |
| Lilly USA, LLC | $62.55 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $48.76 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $46.63 | 3 | $0 (2018) |
| Eisai Inc. | $38.13 | 2 | $0 (2020) |
| Amarin Pharma Inc. | $37.76 | 2 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $37.40 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $37.31 | 2 | ABBVIE INC. ($22.01) |
| 2021 | $223.83 | 14 | AbbVie Inc. ($58.89) |
| 2020 | $245.39 | 14 | GlaxoSmithKline, LLC. ($57.24) |
| 2019 | $160.24 | 11 | GlaxoSmithKline, LLC. ($79.01) |
| 2018 | $81.05 | 6 | Lilly USA, LLC ($23.91) |
| 2017 | $223.08 | 18 | GlaxoSmithKline, LLC. ($56.92) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/31/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Neuroscience | ||||||
| 01/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Obesity | ||||||
| 11/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Obesity | ||||||
| 09/08/2021 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ALLERGY | ||||||
| 08/24/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: VACCINES | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: VACCINES | ||||||
| 04/20/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
| 03/17/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/20/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: VACCINE | ||||||
| 11/13/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Cardiovascular | ||||||
| 10/20/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Neurology | ||||||
| 10/12/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Diabetes | ||||||
| 07/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 07/07/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: Neurology | ||||||
| 07/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 957 | 1,187 | $187,141 | $73,310 |
| 2022 | 10 | 832 | 1,020 | $159,098 | $72,141 |
| 2021 | 12 | 848 | 995 | $151,794 | $72,103 |
| 2020 | 11 | 766 | 924 | $145,487 | $59,731 |
Total Patients
3,403
Total Services
4,126
Medicare Billing
$277,286
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 399 | $100,149 | $31,206 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 135 | 135 | $35,775 | $17,014 | 47.6% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 122 | 124 | $17,183 | $8,909 | 51.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 123 | 125 | $5,500 | $3,681 | 66.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 22 | $8,206 | $3,490 | 42.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,804 | $3,395 | 49.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 100 | 100 | $3,600 | $1,785 | 49.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 129 | 183 | $2,208 | $1,498 | 67.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,458 | $845.64 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,492 | $760.57 | 30.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $672.00 | $471.20 | 70.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $968.00 | $208.57 | 21.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 21 | $126.00 | $46.20 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 453 | $104,135 | $39,572 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 144 | 144 | $30,340 | $18,431 | 60.7% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 74 | 74 | $5,994 | $5,072 | 84.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 41 | $6,599 | $2,656 | 40.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 129 | 129 | $3,687 | $2,305 | 62.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 78 | $3,397 | $2,210 | 65.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 29 | 29 | $2,175 | $1,215 | 55.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 21 | $945.00 | $306.75 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 30 | 30 | $1,619 | $300.85 | 18.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 21 | $207.00 | $72.39 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 239 | 361 | $79,420 | $30,350 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 160 | 160 | $28,800 | $20,694 | 71.9% |
About Dr. Jessica Starner, M.D
Dr. Jessica Starner, M.D is a Family Medicine healthcare provider based in Shrewsbury, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841471596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Starner, M.D has received a total of $970.90 in payments from pharmaceutical and medical device companies, with $37.31 received in 2022. These payments were reported across 65 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($970.90).
As a Medicare-enrolled provider, Starner has provided services to 3,403 Medicare beneficiaries, totaling 4,126 services with total Medicare billing of $277,286. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Shrewsbury, PA
- Active Since 11/23/2007
- Last Updated 12/20/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841471596
Products in Payments
- ANORO (Drug) $79.01
- Ozempic (Drug) $69.75
- TRULICITY (Drug) $62.55
- SHINGRIX (Biological) $54.07
- UBRELVY (Drug) $53.14
- XARELTO (Drug) $48.76
- VRAYLAR (Drug) $41.38
- Dayvigo (Drug) $38.13
- Vascepa (Drug) $37.76
- Trintellix (Drug) $37.40
- Myrbetriq (Drug) $32.20
- Aimovig (Biological) $31.88
- BREO (Drug) $31.56
- Wegovy (Drug) $30.22
- QULIPTA (Drug) $22.01
- FLULAVAL QUADRIVALENT (Biological) $19.63
- AUVI-Q (Drug) $19.55
- GARDASIL 9 (Biological) $19.07
- VIBERZI (Drug) $18.71
- ANORO ELLIPTA (Drug) $18.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shrewsbury
Dr. Adedamola Falokun, M.d, M.D
Family Medicine — Payments: $75,582
Family Medicine $75,582
Dr. Lauren Heagy, M.d, M.D
Family Medicine — Payments: $2,442
Family Medicine $2,442
Nandita Kinley, M.d, M.D
Family Medicine — Payments: $1,813
Family Medicine $1,813
Amy Pedone, M.d, M.D
Family Medicine — Payments: $1,307
Family Medicine $1,307
Mary Mccotter Desi, M.d, M.D
Family Medicine — Payments: $1,100
Family Medicine $1,100
Claudia Huegel, M.d, M.D
Family Medicine — Payments: $918.17
Family Medicine $918.17